{Backed by}
•
anomaly raises $2.6M Pre-seed →
Building The Future of
Ingredient Supply Chains
Anomaly develops functional ingredients using advanced fermentation.
We engineer microbes into micro-factories that transform simple sugars into functional ingredients for nutrition, crop protection, and personal care.
By decoupling production from biological and environmental constraints, we’re replacing fragile ingredient supply chains with scalable, on-demand, and globally resilient biomanufacturing.
{Biology at Scale}
A step change from current extraction-based methods
We focus on producing functional ingredients using advanced fermentation; all we need is sugar, water, electricity, and a tank.
{Journal}
From the Lab
Follow our work, research, and thinking as we reimagine biology at scale for humanity.
{WE'RE JUST GETTING STARTEd}
Investors
US$2.6Mn for anomalous behavior
Pebblebed
San Francisco, CA
Sean Hunt
CTO & Co-Founder of Solugen
Eben Bayer
CEO & Co-Founder of Ecovative
Akshay Kothari
COO of Notion
Mithun Sacheti
Co-founder of CaratLane
Sumit Jain
GP at MLB
Pradeep Dadha
CEO & Founder of Netmeds
Roel Janssen
Solo GP at Undivided Capital
And More!
We’re backed by a group of exceptional people whose belief and support make all the difference.
{Backed by}
•
anomaly raises $2.6M Pre-seed →
Building The Future of
Ingredient Supply Chains
Anomaly develops functional ingredients using advanced fermentation.
We engineer microbes into micro-factories that transform simple sugars into functional ingredients for nutrition, crop protection, and personal care.
By decoupling production from biological and environmental constraints, we’re replacing fragile ingredient supply chains with scalable, on-demand, and globally resilient biomanufacturing.
{Biology at Scale}
A step change from current extraction-based methods
We focus on producing functional ingredients using advanced fermentation; all we need is sugar, water, electricity, and a tank.
{Journal}
From the Lab
Follow our work, research, and thinking as we reimagine biology at scale for humanity.
{WE'RE JUST GETTING STARTEd}
Investors
US$2.6Mn for anomalous behavior
Pebblebed
San Francisco, CA
Sean Hunt
CTO & Co-Founder of Solugen
Eben Bayer
CEO & Co-Founder of Ecovative
Akshay Kothari
COO of Notion
Mithun Sacheti
Co-Founder of CaratLane
Sumit Jain
GP at MLB
Pradeep Dadha
CEO & Founder of Netmeds
Roel Janssen
Solo GP at Undivided Capital
And More!
We’re backed by a group of exceptional people whose belief and support make all the difference.
{Backed by}
•
anomaly raises $2.6M Pre-seed →
Building The Future of
Ingredient Supply Chains
Anomaly develops functional ingredients using advanced fermentation.
We engineer microbes into micro-factories that transform simple sugars into functional ingredients for nutrition, crop protection, and personal care.
By decoupling production from biological and environmental constraints, we’re replacing fragile ingredient supply chains with scalable, on-demand, and globally resilient biomanufacturing.
{Biology at Scale}
A step change from current extraction-based methods
We focus on producing functional ingredients using advanced fermentation; all we need is sugar, water, electricity, and a tank.
{Journal}
From the Lab
Follow our work, research, and thinking as we reimagine biology at scale for humanity.
{WE'RE JUST GETTING STARTEd}
Investors
US$2.6Mn for anomalous behavior
Pebblebed
San Francisco, CA
Sean Hunt
CTO & Co-Founder of Solugen
Eben Bayer
CEO & Co-Founder of Ecovative
Akshay Kothari
COO of Notion
Mithun Sacheti
Co-Founder of CaratLane
Sumit Jain
GP at MLB
Pradeep Dadha
CEO & Founder of Netmeds
Roel Janssen
Solo GP at Undivided Capital
And More!
We’re backed by a group of exceptional people whose belief and support make all the difference.